Lannett NIACIN ER 1,000 mg Recall Affects 46,848 Bottles Nationwide (2025)
Lannett Company, Inc. recalled 46,848 bottles of NIACIN Extended-release Tablets, 1,000 mg, Rx Only, distributed nationwide. The product failed dissolution specifications. Patients and healthcare providers should stop using it immediately and await recall instructions.
About This Product
NIACIN Extended-release tablets are a prescription-grade form of vitamin B3 used to treat cholesterol and other conditions under medical supervision. The product discussed is 1,000 mg per tablet and distributed nationwide in 90-tablet bottles.
Why This Is Dangerous
The dissolution failure means the tablet may not dissolve properly in the stomach, potentially reducing therapeutic effect and leading to ineffective treatment.
Industry Context
This recall is not stated as part of a broader industry pattern.
Real-World Impact
Consumers may require alternatives or adjustments to therapy. The recall impacts patients relying on prescribed Niacin ER without assurance of dissolution performance until guidance is provided.
Practical Guidance
How to identify if yours is affected
- 1. Locate NDC 62175-322-46 on your NIACIN bottle.
- 2. Check the lot numbers listed in the recall details: 21264027A, 22266446A, 22266901A, 22267553A, 22267554A, 22267555A, 22267992A, 22267993A, 22267994A.
- 3. Review expiration dates: 10/30/2025 onward through 05/31/2026.
- 4. If your bottle matches any of these identifiers, stop using it and contact the manufacturer for guidance.
Where to find product info
Label on the bottle shows NDC, lot number, and expiration date. The official recall notice will provide refund or replacement instructions.
What timeline to expect
Refunds or replacements are typically processed within 4-8 weeks after proof of purchase or return is received.
If the manufacturer is unresponsive
- Document all contact attempts with the manufacturer.
- File a complaint with the FDA if the company does not respond within a reasonable time.
- Consider legal counsel if significant injuries or losses occur and the company remains unresponsive.
How to prevent similar issues
- Always verify NDC and lot numbers when receiving prescription medications.
- Compare recall numbers with FDA notices and maintain a record of batch information.
- Ask pharmacists about safety alerts when starting or continuing therapy.
Documentation advice
Keep the original bottle, packaging, and recall notice. Photograph the label showing NDC, lot, and expiration. Save receipts and correspondence with the manufacturer.
Product Details
NDC: 62175-322-46. Pack: 90 tablets per bottle. Quantity recalled: 46,848 bottles. Distribution: Nationwide in the USA. Sold as NIACIN Extended-release Tablets, 1,000 mg, Rx Only. Lot numbers and expirations include: 21264027A Exp 10/30/2025; 22266446A Exp 12/31/2025; 22266901A Exp 02/28/2026; 22267553A Exp 03/31/2026; 22267554A Exp 02/28/2026; 22267555A Exp 02/28/2026; 22267992A Exp 04/30/2026; 22267993A; 22267994A Exp 05/31/2026.
Reported Incidents
No injuries or incidents have been reported.